Langerhans cell histiocytosis with refractory central nervous system involvement responsive to infliximab

J Neurol Neurosurg Psychiatry. 2012 May;83(5):573-5. doi: 10.1136/jnnp-2011-300575. Epub 2011 Aug 19.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Brain / drug effects
  • Brain / pathology
  • Cognition Disorders / complications
  • Cognition Disorders / drug therapy*
  • Drug Resistance / drug effects*
  • Dysarthria / complications
  • Dysarthria / drug therapy
  • Histiocytosis, Langerhans-Cell / complications
  • Histiocytosis, Langerhans-Cell / drug therapy*
  • Histiocytosis, Langerhans-Cell / pathology
  • Histiocytosis, Langerhans-Cell / psychology
  • Humans
  • Infliximab
  • Magnetic Resonance Imaging / psychology
  • Male
  • Middle Aged

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab